rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Deborah Dunsire

Director

Company insider

Files Form 4 as: Director, McKesson; Director, Ultragenyx Pharmaceutical; Director, Syros Pharmaceuticals; Director, Alexion Pharmaceuticals; Director, Allergan; President, CEO, Millennium Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
333
Buys
1
Sells
7
Bought
$12K
Sold
$2.8M
Companies
6
Companies where not an officer
5
First trade
6 Mar 2006
Last trade
22 Jul 2026
Last filed
23 Jul 2026

Companies traded

Where they are an officer
Millennium PharmaceuticalsDirector, Officer · last 14 May 20080 buys · 7 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MCK McKessonDirector · Health Care Distribution · last 22 Jul 20260 buys · 0 sells
RARE Ultragenyx PharmaceuticalDirector · Biotechnology · last 14 May 20260 buys · 0 sells
Syros PharmaceuticalsDirector · last 5 Jun 20240 buys · 0 sells
Alexion PharmaceuticalsDirector · last 21 Jul 20210 buys · 0 sells
AllerganDirector · last 17 Mar 20151 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
22 Jul 2026filed 23 Jul 2026MCK McKessonoption or derivative · Health Care DistributionSEC FORM 4 Code A—277 at $0.00filing
22 Jul 2026filed 23 Jul 2026MCK McKessonoption or derivative · Health Care DistributionSEC FORM 4 Code A—277 at $0.00filing
14 May 2026filed 18 May 2026RARE Ultragenyx PharmaceuticalBiotechnologySEC FORM 4 Code A—7,751 at $0.00filing
14 May 2026filed 18 May 2026RARE Ultragenyx Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code A—14,058 at $0.00filing
14 May 2026filed 18 May 2026RARE Ultragenyx Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code A—14,058 at $0.00filing
14 May 2026filed 18 May 2026RARE Ultragenyx PharmaceuticalBiotechnologySEC FORM 4 Code A—7,751 at $0.00filing
30 Jul 2025filed 31 Jul 2025MCK McKessonoption or derivative · Health Care DistributionSEC FORM 4 Code A—301 at $0.00filing
15 May 2025filed 19 May 2025RARE Ultragenyx Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code A—10,787 at $0.00filing
15 May 2025filed 19 May 2025RARE Ultragenyx PharmaceuticalBiotechnologySEC FORM 4 Code A—5,740 at $0.00filing
31 Jul 2024filed 1 Aug 2024MCK McKessonoption or derivative · Health Care DistributionSEC FORM 4 Code A—349 at $0.00filing
18 Jun 2024filed 20 Jun 2024RARE Ultragenyx Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code A—9,900 at $0.00filing
18 Jun 2024filed 20 Jun 2024RARE Ultragenyx PharmaceuticalBiotechnologySEC FORM 4 Code A—5,345 at $0.00filing
5 Jun 2024filed 7 Jun 2024Syros Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—6,000 at $0.00filing
5 Jun 2024filed 7 Jun 2024Syros Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—4,000 at $0.00filing
3 Jun 2024filed 4 Jun 2024MCK McKessonoption or derivative · Health Care DistributionSEC FORM 4 Code A—56 at $0.00filing
1 Jun 2024filed 4 Jun 2024Syros Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—4,000 at $0.00filing
1 Jun 2024filed 4 Jun 2024Syros PharmaceuticalsSEC FORM 4 Code M—4,000filing
7 Jun 2023filed 9 Jun 2023RARE Ultragenyx Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code A—7,110 at $0.00filing
7 Jun 2023filed 9 Jun 2023RARE Ultragenyx PharmaceuticalBiotechnologySEC FORM 4 Code A—3,860 at $0.00filing
1 Jun 2023filed 2 Jun 2023Syros Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—6,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.